Marketing-authorisation holder · United States
ADMA Biologics, Inc.
5 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
5 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Asceniv5g/50ml · Injection | Immune globulin intravenous, human | United States | Marketed | 2019 |
| Bivigam5gm/50ml · Injection | Immune globulin intravenous | United States | Marketed | 2012 |
| Bivigam10gm/100ml · Injection | Immune globulin intravenous | United States | Marketed | 2012 |
| Nabi-HB312iu/ml · Injection | Hepatitis b immunoglobulin | United States | Not marketed | 2001 |
| Nabi-HB1560iu/5ml · Injection | Hepatitis b immunoglobulin | United States | Marketed | 2001 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 5 | 5 | 0 |